Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance.

Humans Clinical Relevance Neoplastic Cells, Circulating / pathology Melanoma / genetics Cell Line, Tumor Epithelial-Mesenchymal Transition / genetics
EMT gene signature circulating melanoma cells metastasis responder to therapy

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
22 Jul 2023
Historique:
received: 28 06 2023
revised: 14 07 2023
accepted: 20 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

The most promising method for monitoring patients with minimal morbidity is the detection of circulating melanoma cells (CMCs). We have shown that CD45

Identifiants

DOI: 10.3390/ijms241411792 PMID: 37511550 PMC: PMC10380315
pubmed: 37511550
pii: ijms241411792
doi: 10.3390/ijms241411792
pmc: PMC10380315
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2017 Mar 24;7:43464
pubmed: 28337998
Biomedicines. 2021 Sep 08;9(9):
pubmed: 34572366
Br J Dermatol. 2009 Feb;160(2):338-44
pubmed: 19067715
Br J Dermatol. 2013 Jul;169(1):221-2
pubmed: 23448399
Nat Rev Mol Cell Biol. 2020 Jun;21(6):341-352
pubmed: 32300252
Clin Cancer Res. 2008 Oct 1;14(19):6302-9
pubmed: 18829513
EMBO Mol Med. 2014 Oct 30;6(11):1371-86
pubmed: 25358515
Breast Cancer Res. 2018 Jun 8;20(1):48
pubmed: 29884204
N Engl J Med. 2004 Aug 19;351(8):781-91
pubmed: 15317891
Cancer Cell. 2013 Oct 14;24(4):466-80
pubmed: 24075834
Clin Cancer Res. 2008 May 1;14(9):2593-600
pubmed: 18451221
Arch Pathol Lab Med. 2010 Dec;134(12):1750-7
pubmed: 21128771
Transl Oncol. 2020 Jun;13(6):100773
pubmed: 32334405
Mod Pathol. 2012 Aug;25(8):1169-75
pubmed: 22555176
Biomolecules. 2020 Nov 16;10(11):
pubmed: 33207810
Nat Rev Clin Oncol. 2014 Jul;11(7):401-12
pubmed: 24821215
J Invest Dermatol. 2013 Jun;133(6):1460-2
pubmed: 23673501
Ann Transl Med. 2014 Nov;2(11):108
pubmed: 25489582
Cancer Treat Res Commun. 2020;25:100262
pubmed: 33338742
Transl Cancer Res. 2020 Nov;9(11):6639-6651
pubmed: 35117274
Oncogene. 2015 Oct 1;34(40):5175-86
pubmed: 25619830
Arch Dermatol Res. 2014 Aug;306(6):527-37
pubmed: 24902661
Front Oncol. 2015 Jul 20;5:155
pubmed: 26258068
Front Med. 2018 Aug;12(4):361-373
pubmed: 30043221
Genes Dev. 2022 Apr 1;36(7-8):391-407
pubmed: 35487686
Trends Mol Med. 2006 Mar;12(3):130-9
pubmed: 16488189
Clin Cancer Res. 1999 Aug;5(8):1950-60
pubmed: 10473071
Semin Cancer Biol. 2012 Oct;22(5-6):396-403
pubmed: 22554795
Br J Cancer. 2020 Mar;122(7):1059-1067
pubmed: 32037400
Front Oncol. 2022 Dec 15;12:1089108
pubmed: 36591516
EMBO J. 2021 Sep 15;40(18):e108647
pubmed: 34459003
Mod Pathol. 2007 Jan;20(1):102-7
pubmed: 17143262
Front Oncol. 2015 Feb 02;5:13
pubmed: 25699236
Oncoimmunology. 2015 Dec 10;5(4):e1102827
pubmed: 27141386
Front Genet. 2023 Apr 03;14:1152470
pubmed: 37077538
Cell Death Discov. 2017 Mar 06;3:17005
pubmed: 28280601
Acta Oncol. 2011 Jun;50(5):700-10
pubmed: 21261508
Clin Chem Lab Med. 2007;45(11):1488-94
pubmed: 17924845
Oncotarget. 2017 May 26;8(46):81558-81571
pubmed: 29113414
Cancer Lett. 2007 Aug 18;253(2):180-204
pubmed: 17314005
Forensic Sci Int. 2021 Apr;321:110720
pubmed: 33639416
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Cell Mol Immunol. 2023 Apr;20(4):318-340
pubmed: 36823234
Tumour Biol. 2016 Jan;37(1):185-97
pubmed: 26602382
PLoS One. 2012;7(7):e40378
pubmed: 22911700
Clin Cancer Res. 2018 Aug 15;24(16):3917-3927
pubmed: 29739791
Cancer Lett. 2010 Feb 1;288(1):99-106
pubmed: 19619935
Nat Rev Cancer. 2019 Oct;19(10):553-567
pubmed: 31455893
Clin Cancer Res. 1999 Jul;5(7):1843-8
pubmed: 10430090
Int J Mol Sci. 2021 Nov 17;22(22):
pubmed: 34830300
J Clin Oncol. 2003 Mar 1;21(5):767-73
pubmed: 12610172
Clin Chem. 2015 Jan;61(1):259-66
pubmed: 25336717
BMC Cancer. 2014 Jun 11;14:423
pubmed: 24915896
Cells. 2020 Mar 04;9(3):
pubmed: 32143517
Signal Transduct Target Ther. 2021 Dec 20;6(1):424
pubmed: 34924562
Biomark Res. 2021 Nov 19;9(1):85
pubmed: 34798902
Nature. 2008 Jan 17;451(7176):345-9
pubmed: 18202660
Int J Cancer. 2012 Feb 15;130(4):808-16
pubmed: 21387303
Dev Cell. 2008 Jun;14(6):818-29
pubmed: 18539112
Oncologist. 2020 Mar;25(3):e520-e527
pubmed: 32162809
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1127-32
pubmed: 22210108
Ann Oncol. 2014 Aug;25(8):1506-16
pubmed: 24651410
BMC Cancer. 2012 May 16;12:178
pubmed: 22591372
Sci Adv. 2022 Aug 5;8(31):eabj8002
pubmed: 35921406
Mol Oncol. 2022 May;16(10):1969-1985
pubmed: 34866317
Cancer Cell. 2021 Aug 9;39(8):1150-1162.e9
pubmed: 34115987
Cancer Res. 2012 Dec 15;72(24):6382-92
pubmed: 23222305
J Hematol Oncol. 2019 May 14;12(1):48
pubmed: 31088479
Int J Oncol. 2011 Mar;38(3):755-60
pubmed: 21206975
Cell Rep. 2014 May 8;7(3):645-53
pubmed: 24746818
Nat Rev Cancer. 2002 Jun;2(6):442-54
pubmed: 12189386
Front Biosci (Landmark Ed). 2020 Jan 1;25(4):606-631
pubmed: 31585907
Cell Stem Cell. 2015 Jan 8;16(1):67-79
pubmed: 25575080
Cancer Cell. 2012 Dec 11;22(6):725-36
pubmed: 23201165
Am J Pathol. 1998 Sep;153(3):865-73
pubmed: 9736035
J Am Coll Surg. 2018 Jul;227(1):116-124
pubmed: 29746918
Breast Cancer Res. 2012 Jan 20;14(1):R15
pubmed: 22264265
Cells. 2019 Sep 20;8(10):
pubmed: 31547193
Connect Tissue Res. 2015;56(5):403-13
pubmed: 26291767
Science. 2013 Feb 1;339(6119):580-4
pubmed: 23372014
Pigment Cell Res. 2005 Jun;18(3):150-9
pubmed: 15892711
Clin Chem. 2018 Feb;64(2):297-306
pubmed: 29122836
EMBO Mol Med. 2016 Oct 4;8(10):1143-1161
pubmed: 27596438
Front Mol Biosci. 2020 May 29;7:92
pubmed: 32548126
Arch Pharm Res. 2021 Mar;44(3):281-292
pubmed: 33768509
Nat Rev Cancer. 2003 Aug;3(8):559-70
pubmed: 12894244
Oncotarget. 2017 Feb 28;8(9):15520-15538
pubmed: 28107182
Mol Med Rep. 2019 Jan;19(1):601-608
pubmed: 30483792
J Invest Dermatol. 2013 Jun;133(6):1582-90
pubmed: 23223143
Cells. 2020 Jul 01;9(7):
pubmed: 32630254
Mol Cancer Ther. 2012 Nov;11(11):2526-34
pubmed: 22973057
Br J Cancer. 2023 May;128(9):1742-1752
pubmed: 36823365
Nat Rev Cancer. 2009 Apr;9(4):265-73
pubmed: 19262571
Nat Cell Biol. 2019 Jan;21(1):102-112
pubmed: 30602760
Pigment Cell Melanoma Res. 2014 Jan;27(1):19-36
pubmed: 24106873
Mol Oncol. 2017 Jan;11(1):28-39
pubmed: 28085222
Cancer Res. 2014 Aug 1;74(15):4196-207
pubmed: 24934811
Br J Cancer. 2014 Feb 18;110(4):958-66
pubmed: 24300972
Int J Mol Sci. 2023 Feb 16;24(4):
pubmed: 36835424
J Invest Dermatol. 2015 Aug;135(8):2040-2048
pubmed: 25830652
Anticancer Res. 2021 Feb;41(2):661-670
pubmed: 33517270
Am J Pathol. 2012 Jun;180(6):2479-89
pubmed: 22503751
Anal Biochem. 1987 Apr;162(1):156-9
pubmed: 2440339

Auteurs

Maria Cristina Rapanotti (MC)

Department of Anatomic Pathology, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
Department of Laboratory Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Elisa Cugini (E)

Department of Laboratory Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Elena Campione (E)

Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.

Cosimo Di Raimondo (C)

Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
ORCID: 0000-0003-4691-9381

Gaetana Costanza (G)

Department of Laboratory Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
ORCID: 0000-0002-1115-4270

Piero Rossi (P)

Surgery Division, Department of Surgery Sciences, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.

Amedeo Ferlosio (A)

Department of Anatomic Pathology, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Sergio Bernardini (S)

Department of Laboratory Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Augusto Orlandi (A)

Department of Anatomic Pathology, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
ORCID: 0000-0001-7202-5854

Anastasia De Luca (A)

Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy.
ORCID: 0000-0002-6532-989X

Luca Bianchi (L)

Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
ORCID: 0000-0001-8697-6896

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Epithelial-to-Mesenchymal Transition Gene...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Évaluation des résultats des patients › Pertinence clinique › Epithelial-to-Mesenchymal Transition Gene...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Cellules tumorales circulantes › Epithelial-to-Mesenchymal Transition Gene...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › Epithelial-to-Mesenchymal Transition Gene...
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Lignée cellulaire tumorale › Epithelial-to-Mesenchymal Transition Gene...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transdifférenciation cellulaire › Transition épithélio-mésenchymateuse › Epithelial-to-Mesenchymal Transition Gene...